These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2036076)

  • 1. Transfusion associated graft-versus-host disease after cardiac surgery: response to antithymocyte-globulin and corticosteroid therapy.
    Prince M; Szer J; van der Weyden MB; Pedersen JS; Holdsworth RF; Whyte G
    Aust N Z J Med; 1991 Feb; 21(1):43-6. PubMed ID: 2036076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of steroid-resistant acute graft-versus-host disease with rabbit antithymocyte globulin.
    McCaul KG; Nevill TJ; Barnett MJ; Toze CL; Currie CJ; Sutherland HJ; Conneally EA; Shepherd JD; Nantel SH; Hogge DE; Klingemann HG
    J Hematother Stem Cell Res; 2000 Jun; 9(3):367-74. PubMed ID: 10894358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: a randomized trial comparing antithymocyte globulin and corticosteroids.
    Doney KC; Weiden PL; Storb R; Thomas ED
    Am J Hematol; 1981; 11(1):1-8. PubMed ID: 7023233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
    Ogawa H; Ikegame K; Yoshihara S; Kawakami M; Fujioka T; Masuda T; Taniguchi Y; Hasei H; Kaida K; Inoue T; Kim EH; Kawase I
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion-associated graft-vs-host disease. A fatal case caused by blood from an unrelated HLA homozygous donor.
    Gorman TE; Julius CJ; Barth RF; Ng A; Kennedy MS; Prior TW; Allen J; Lasky LC
    Am J Clin Pathol; 2000 May; 113(5):732-7. PubMed ID: 10800407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of severe aplastic anemia: comparison of bone marrow transplantation to immunotherapy.
    Tzeng CH; Chen PM; Chuang MW; Liu JH; Hsieh RK; Liu CJ; Fan S; Chen KY; Yung CH; Wang SY
    Zhonghua Yi Xue Za Zhi (Taipei); 1989 Jan; 43(1):21-8. PubMed ID: 2670137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of moderate and severe acute GVHD after allogeneic bone marrow transplantation.
    Hings IM; Severson R; Filipovich AH; Blazar BR; Kersey JH; Ramsay NK; McGlave PB; Weisdorf DJ
    Transplantation; 1994 Aug; 58(4):437-42. PubMed ID: 8073512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia.
    Kekre N; Zhang Y; Zhang MJ; Carreras J; Ahmed P; Anderlini P; Atta EH; Ayas M; Boelens JJ; Bonfim C; Deeg HJ; Kapoor N; Lee JW; Nakamura R; Pulsipher MA; Eapen M; Antin JH
    Haematologica; 2017 Jul; 102(7):1291-1298. PubMed ID: 28341733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.
    Bryant A; Mallick R; Huebsch L; Allan D; Atkins H; Anstee G; Sabloff M; Scrivens N; Maze D; Bredeson C; Kekre N
    Biol Blood Marrow Transplant; 2017 Dec; 23(12):2096-2101. PubMed ID: 28821454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion associated graft versus host disease in an immunocompetent individual following coronary artery bypass grafting.
    Ahya R; Douglas JG; Watson HG
    Heart; 1998 Sep; 80(3):299-300. PubMed ID: 9875094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-human thymocyte globulin (ATG) for prophylaxis and treatment of graft-versus-host disease in recipients of allogeneic marrow grafts.
    Weiden PL; Doney K; Storb R; Thomas ED
    Transplant Proc; 1978 Mar; 10(1):213-6. PubMed ID: 345561
    [No Abstract]   [Full Text] [Related]  

  • 13. Failure of early administration of antithymocyte globulin to lessen graft-versus-host disease in human allogeneic marrow transplant recipients.
    Doney KC; Weiden PL; Storb R; Thomas ED
    Transplantation; 1981 Feb; 31(2):141-3. PubMed ID: 7020176
    [No Abstract]   [Full Text] [Related]  

  • 14. T-cell depleting antibodies: new hope for induction of allograft tolerance in bone marrow transplantation?
    Simpson D
    BioDrugs; 2003; 17(3):147-54. PubMed ID: 12749751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunosuppressive treatment of severe aplastic anemia with high-dose methylprednisolone and antithymocyte globulin in 2 patients].
    Urban C; Zoubek A; Krottmayer G; Slavc I; Kaulfersch W; Wagner K
    Wien Klin Wochenschr; 1984 Mar; 96(6):225-30. PubMed ID: 6610992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome: a study from the French Society of Bone Marrow Transplantation and Cellular Therapy.
    Duléry R; Mohty M; Duhamel A; Robin M; Beguin Y; Michallet M; Vigouroux S; Lioure B; Garnier A; El Cheikh J; Bulabois CE; Huynh A; Bay JO; Daguindau E; Ceballos P; Clément L; Dauriac C; Maillard N; Legrand F; Cornillon J; Guillerm G; François S; Lapusan S; Chevallier P; Damaj G; Yakoub-Agha I
    Biol Blood Marrow Transplant; 2014 May; 20(5):646-54. PubMed ID: 24462982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of acute graft-versus-host disease following reduced-intensity stem-cell transplantation from an HLA-identical related donor.
    Murashige N; Kami M; Mori S; Katayama Y; Kobayashi K; Onishi Y; Hori A; Kishi Y; Hamaki T; Tajima K; Kanda Y; Tanosaki R; Takaue Y
    Am J Hematol; 2008 Aug; 83(8):630-4. PubMed ID: 18454459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation.
    Hutchinson K; Kopko PM; Muto KN; Tuscano J; O'Donnell RT; Holland PV; Richman C; Paglieroni TG; Wun T
    Transfusion; 2002 Dec; 42(12):1567-72. PubMed ID: 12473136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft-versus-host disease after marrow transplantation.
    Storb R
    Prog Clin Biol Res; 1986; 224():139-57. PubMed ID: 3540990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal graft-versus-host disease following transfusion during open heart surgery.
    Aso T; Asano Y; Harada M; Kudo J; Fujimoto K; Okamura T; Tsuda Y; Niho Y
    Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1064-71. PubMed ID: 2588955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.